Nobiletin acts as a potential anticancer agent against osteosarcoma by regulating ERK and AKT signaling pathways July 2, 2014 by BDPS Admin Fu-Wen Niu, Yong-Jie Zhang, Kun Li, Mao-Shu Zhang Download
